Validation of Peptest™ for the Detection of Reflux in Cough
Launched by HULL UNIVERSITY TEACHING HOSPITALS NHS TRUST · Feb 20, 2019
Trial Information
Current as of May 08, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • A negative score for airway reflux (HARQ score \<13).
- • Provision of informed consent.
- Exclusion Criteria:
- • Participants with a positive score for airway reflux (HARQ score \>13).
- • Chronic respiratory disease.
- • Acute gastro-respiratory illness at the time of the study.
- • Participants who will be physically unable to undergo sputum collection or cough induction.
- • Those who are unwilling to undergo cough challenge and induction of cough.
- • Smoking or consumption of food, caffeinated or carbonated beverages for 30 minutes prior to sample collection.
About Hull University Teaching Hospitals Nhs Trust
Hull University Teaching Hospitals NHS Trust is a leading healthcare organization dedicated to delivering high-quality patient care, education, and research. Located in Hull, England, the Trust encompasses a range of hospitals and healthcare services, providing a comprehensive spectrum of clinical specialties. With a strong commitment to advancing medical science, the Trust actively sponsors and conducts clinical trials that aim to improve patient outcomes and contribute to evidence-based practice. By collaborating with academic partners and leveraging its state-of-the-art facilities, Hull University Teaching Hospitals NHS Trust fosters an innovative research environment that prioritizes patient safety and ethical standards.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cottingham, Yorkshire, United Kingdom
Patients applied
Trial Officials
Alyn Morice, MD, FRCP
Principal Investigator
Hull University Teaching Hospitals NHS Trust
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials